ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : PROTEIN PHOSPHATASE
Field of Research : Endocrinology
Clear All
Filter by Field of Research
Endocrinology (50)
Biochemistry and Cell Biology (1)
Oncology And Carcinogenesis (1)
Protein Targeting And Signal Transduction (1)
Filter by Socio-Economic Objective
Endocrine organs and diseases (incl. diabetes) (1)
Environmental health (1)
Industrial chemicals and related products (1)
Filter by Funding Provider
National Health and Medical Research Council (49)
Australian Research Council (1)
Filter by Status
Closed (50)
Filter by Scheme
NHMRC Project Grants (39)
Project Grants (6)
Discovery Projects (1)
Early Career Fellowships (1)
NHMRC Development Grants (1)
NHMRC Postgraduate Scholarships (1)
Research Fellowships (1)
Filter by Country
Australia (2)
Filter by Australian State/Territory
SA (1)
VIC (1)
  • Researchers (2)
  • Funded Activities (50)
  • Organisations (16)
  • Funded Activity

    Hormonal Regulation Of Protein Phosphorylation

    Funder
    National Health and Medical Research Council
    Funding Amount
    $116,137.00
    More information
    Funded Activity

    Hepatic Oxidative Stress, PTPs & STAT Signalling In Obesity

    Funder
    National Health and Medical Research Council
    Funding Amount
    $1,086,547.00
    Summary
    Obesity is increasing at an alarming rate worldwide and is a leading cause of morbidity and mortality. Obesity is causally linked to the development of insulin resistance, a prelude to type 2 diabetes. In this proposal we will define a novel liver centric mechanism by which insulin resistance and oxidative stress may promote the development of morbid obesity, type 2 diabetes and liver disease.
    More information
    Funded Activity

    Regulation Of Hypothalamic Insulin & Leptin Signalling By TCPTP

    Funder
    National Health and Medical Research Council
    Funding Amount
    $758,504.00
    Summary
    Insulin & leptin signal in the brain to lower blood glucose, suppress food intake, increase activity & increase energy expenditure. Obesity diminishes the abilities of insulin & leptin to signal. This proposal will determine if the enzyme TCPTP terminates insulin & leptin signaling in the brain. Our studies will provide insight into the molecular causes of obesity & may identify a novel therapeutic target for the treatment of obesity & type 2 diabetes.
    More information
    Funded Activity

    Regulation Of Insulin Sensitivity By Reactive Oxygen Species

    Funder
    National Health and Medical Research Council
    Funding Amount
    $564,644.00
    Summary
    In morbid obesity and type 2 diabetes chronic levels of reactive oxygen species (ROS) are detrimental and diminish insulin's ability to maintain normal blood glucose levels. Paradoxically, ROS also promote insulin action by inhibiting enzymes known as protein tyrosine phosphatases (PTPs). This proposal will determine whether the promotion of ROS for the inhibition of PTPs early in the progression of type 2 diabetes may be of therapeutic benefit.
    More information
    Funded Activity

    Regulation Of Insulin Signalling & Glucose Homeostasis By Protein Tyrosine Phosphatases

    Funder
    National Health and Medical Research Council
    Funding Amount
    $503,776.00
    Summary
    Type 2 diabetes has reached epidemic proportions afflicting roughly 6% of the adult population in Western society. Although the underlying genetic causes and the associated pathological symptoms are heterogenous, a common feature is high blood glucose due to peripheral insulin resistance. The molecular basis of insulin resistance is believed to be attributable to defects in insulin receptor (IR) signalling. The IR is a protein tyrosine kinase that phosphorylates itself and downstream substrates .... Type 2 diabetes has reached epidemic proportions afflicting roughly 6% of the adult population in Western society. Although the underlying genetic causes and the associated pathological symptoms are heterogenous, a common feature is high blood glucose due to peripheral insulin resistance. The molecular basis of insulin resistance is believed to be attributable to defects in insulin receptor (IR) signalling. The IR is a protein tyrosine kinase that phosphorylates itself and downstream substrates on tyrosine in response to insulin. Protein tyrosine phosphatases (PTPs) that dephosphorylate the IR and its substrates might be important targets for therapeutic intervention in type 2 diabetes; inhibition of specific PTPs may allow for enhanced insulin-induced signalling to alleviate insulin resistance. This proposal will examine the roles of PTPs and in particular TCPTP in IR signalling in vivo. Our studies will shed light on the molecular mechanisms of IR regulation and function and may provide important insights into novel strategies for enhancing insulin sensitivity in type 2 diabetes.
    Read more Read less
    More information
    Funded Activity

    Regulation By Insulin Of Gene Expression And General Pr Otein Synthesis In Mammalian Liver

    Funder
    National Health and Medical Research Council
    Funding Amount
    $498,284.00
    More information
    Funded Activity

    Membrane Dynamics In Protein Trafficking

    Funder
    National Health and Medical Research Council
    Funding Amount
    $198,440.00
    More information
    Funded Activity

    Factors Regulating The Temporal And Spatial Assembly Of G-protein Coupled Receptor-mediated Arrestin Complexes

    Funder
    National Health and Medical Research Council
    Funding Amount
    $472,770.00
    Summary
    G-protein coupled receptors are proteins that are present at the surface of most cells in the human body. They recognise and bind to specific molecules, such as hormones, the act of which results in a specific signal being transmitted into the cell. This signal alters the function of the cell and so it is critical that it is appropriate, both in type and duration. G-protein coupled receptors and the molecules that activate them provide an essential function within the human body for communicatin .... G-protein coupled receptors are proteins that are present at the surface of most cells in the human body. They recognise and bind to specific molecules, such as hormones, the act of which results in a specific signal being transmitted into the cell. This signal alters the function of the cell and so it is critical that it is appropriate, both in type and duration. G-protein coupled receptors and the molecules that activate them provide an essential function within the human body for communicating between cells, and consequently between organs. They are a major mechanism by which nerve signals are transmitted and hormones regulate bodily functions. They are therefore an important target for pharmaceuticals, with up to 50% of ethical drugs and many drugs of abuse acting upon them. It is critical to understand how these receptors alter cellular function once they receive an appropriate signal, but it is also essential to know how such responses are switched off. Arrestins are proteins within cells that interact with G-protein coupled receptors to 'arrest' their signalling. They desensitise the cell to continuous stimulation, but also act to resensitise the cell to respond to future, separate signals. Recently, they have also been shown to provide alternative mechanisms of altering cellular activity by interacting with other cellular proteins. These interactions greatly increase the potential ways in which a cell can respond once a G-protein coupled receptor is activated. Understanding the resulting complexity is essential if we are to fully exploit the vast therapeutic potential of this important receptor family.
    Read more Read less
    More information
    Funded Activity

    Hormonal Regulation Of Vascular Muscle

    Funder
    National Health and Medical Research Council
    Funding Amount
    $519,036.00
    More information
    Funded Activity

    Regulation Of Growth By Insulin-like Growth Factors And Their Binding Proteins

    Funder
    National Health and Medical Research Council
    Funding Amount
    $550,490.00
    More information

    Showing 1-10 of 50 Funded Activites

    • 1
    • 2
    • 3
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback